Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Liver and Bile

    The global epidemiology of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A systematic review

    Hepatology. 2023;77(4):1335–47

    Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L

    Go to article

    Liver and Bile

    Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: A randomized, placebo-controlled phase 2 trial

    Lancet Gastroenterol Hepatol. 2023;8(6):511–22

    Loomba R, Abdelmalek MF, Armstrong MJ, Jara M, Kjær MS, Krarup N, Lawitz E, Ratziu V, Sanyal AJ, Schattenberg JM, Newsome PN; NN9931-4492 investigators

    Go to article

    Liver and Bile

    Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: A multicenter cohort study

    J Gastroenterol Hepatol. 2023;38(4):648–55

    Cho SH, Song TJ, Park JS, Yoon JH, Yang MJ, Yoon SB, Lee JM, Lee YN, Kim SH, Choi EK, Park SW, Oh D, Park DH, Lee SS, Seo DW, Lee SK, Kim MH

    Go to article

    Liver and Bile

    Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood

    J Hepatol. 2023;78(5):979–88

    Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E

    Go to article

    Liver and Bile

    Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

    Hepatology. 2023;77(4):1095–105

    Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry

    Go to article

    Liver and Bile

    Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated

    J Hepatol. 2023;78(5):989–97

    Atallah E, Grove JI, Crooks C, Burden-Teh E, Abhishek A, Moreea S, Jordan KM, Ala A, Hutchinson D, Aspinall RJ, Murphy R, Aithal GP

    Go to article

    Liver and Bile

    Three-fold increased risk of death in Budd-Chiari syndrome compared to matched controls: A population-based cohort study

    Clin Gastroenterol Hepatol. 2023;21(4):995–1004.e9

    Åberg F, Rajani R, Wester A, Widman L, Hagström H

    Go to article

    Liver and Bile

    Outcome of Budd-Chiari syndrome patients treated with direct oral anticoagulants: An Austrian multicenter study

    Clin Gastroenterol Hepatol. 2023;21(4):978–87.e2

    Semmler G, Lindorfer A, Schäfer B, Bartl S, Hametner-Schreil S, Gensluckner S, Balcar L, Pomej K, Lampichler K, Trauner M, Aigner E, Datz C, Zoller H, Hofer H, Schöfl R, Mandorfer M, Reiberger T, Scheiner B

    Go to article

    Liver and Bile

    Model to predict major complications following liver resection for HCC in patients with metabolic syndrome

    Hepatology. 2023;77(5):1527–39

    Berardi G, Ratti F, Sposito C, Nebbia M, D’Souza DM, Pascual F, Dogeas E, Tohme S, D’Amico FE, Alessandris R, Simonelli I, Del Basso C, Russolillo N, Moro A, Fiorentini G, Serenari M, Rotellar F, Zimmitti G, Famularo S, Ivanics T, Hoffman D, Onkendi E, Essaji Y, Lopez Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Torzilli G, Sapisochin G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon CHD, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Mazzaferro V, Aldrighetti L, Kingham TP

    Go to article